You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
华润医疗(01515.HK)全年综合营业额升逾三成至27.51亿元 末期息8.82港仙
格隆汇 03-26 23:59

格隆汇 3 月 26日丨华润医疗(01515.HK)发布截至2020年12月31日止年度全年业绩公告,集团共实现综合营业额人民币27.51亿元(2019财政年度:人民币21.15亿元),同比增长30.03%。相关的增长主要因收购济南重汽医院及并表多家医院而产生。惟报告期内录得净利润为人民币3.20亿元,母公司拥有人应占年度利润为人民币3.10亿元。基本每股盈利人民币0.25元,建议每股末期股息每股8.82港仙。

截至2020年12月31日,集团在中国9个省、市共管理运营107家医疗机构,集团成员医院年度门诊量和住院量分别为约770.6万和22.0万人次。受到新冠病毒疫情影响,在年初完成了对济南重汽医院收购的情况下,报告期内集团成员医院的医疗业务总收入为人民币约66.44亿元,业务经营情况已自2020年5月份开始显著恢复。

2021年是“十四五”开局之年,集团将坚持以医疗服务为主业,聚焦布局优势专科、并明确专科连锁集群转型的发展定位。在业务发展方面,集团将以专科连锁医院与综合医院为双翼,在地域上将深耕京津冀,长三角和大湾区,并兼顾重点城市群,透过资本运营和市场机制为双引擎以构建医疗服务产业和资本运营良性融合的发展模式。在专科发展方面,集团亦将继续强化临床能力、构建连锁专科业务、创造更优质品牌,发挥华润医疗既有的学科优势,同时利用外延和内生的增长来培育心血管科、脑科、骨科、康复科、消化科和肿瘤科六大学科集群,以强化核心竞争优势、打造华润医疗优势学科品牌。在综合医院的运营方面,集团将加快推进“大专科、强综合”的发展路径,以现有优势专科为基础,持续做精专科、深化综合医院运营体系并提高经营效益。华润医疗将继续秉承“仁心仁术、康泽天下”的企业使命,成为大众信赖、国内一流的医疗产业控股集团。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account